Albemarle Corporation Further Revised its 2022 Outlook


Albemarle Corporation (NYSE:ALB) announced further revision for its full 2022-year guidance, which reflects primarily the additional implementation of index-referenced variable-price contracts for battery grade lithium sales. The company now expects Lithium pricing to be up 140% year-over-year, compared to the prior estimate of up 100% year-over-year.
Net sales are now expected to range from $5.8 billion to $6.2 billion, compared to the previous outlook range of $5.2 billion to $5.6 billion and the Street estimate of $5.44 billion. Adjusted EBITDA is now expected in the range of $2.2 – $2.5 billion, compared to the previous outlook of $1.7 – $2.0 billion.
Adjusted diluted EPS is expected in the range of $12.30 – $15.00, compared to the previous outlook of $9.25 – $12.25 and the Street estimate of $10.88.


Follow us on Google news for more updates and News










Full Disclaimer








>

FREE

Get the most important news and analyses for Free.

Thank you for subscribing.

Something went wrong.